Declaration of interest
SJK, JSF and JSW are inventors on a patent describing the use of Fcp5 for amyloid-targeted immunotherapy.
PDF download + Online access
Issue Purchase
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.
Register now or learn more